Perfluoroalkyl substances in early pregnancy and risk of hypertensive disorders of pregnancy: A prospective cohort study

Background: Perfluoroalkyl substances (PFASs) were reported to be associated with hypertensive disorders of pregnancy (HDP) but the results were inconsistent and prospective data are scarce. We aimed to examine these associations in a large prospective birth cohort study in Shanghai, China. Methods:...

Full description

Bibliographic Details
Main Authors: Xiaona Huo, Rong Huang, Yuexin Gan, Kai Luo, Ruxianguli Aimuzi, Min Nian, Junjie Ao, Liping Feng, Ying Tian, Weiye Wang, Weiping Ye, Jun Zhang
Format: Article
Language:English
Published: Elsevier 2020-05-01
Series:Environment International
Online Access:http://www.sciencedirect.com/science/article/pii/S016041201934293X
id doaj-b10280cfd73c4954a4473c3fd3723ce2
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Xiaona Huo
Rong Huang
Yuexin Gan
Kai Luo
Ruxianguli Aimuzi
Min Nian
Junjie Ao
Liping Feng
Ying Tian
Weiye Wang
Weiping Ye
Jun Zhang
spellingShingle Xiaona Huo
Rong Huang
Yuexin Gan
Kai Luo
Ruxianguli Aimuzi
Min Nian
Junjie Ao
Liping Feng
Ying Tian
Weiye Wang
Weiping Ye
Jun Zhang
Perfluoroalkyl substances in early pregnancy and risk of hypertensive disorders of pregnancy: A prospective cohort study
Environment International
author_facet Xiaona Huo
Rong Huang
Yuexin Gan
Kai Luo
Ruxianguli Aimuzi
Min Nian
Junjie Ao
Liping Feng
Ying Tian
Weiye Wang
Weiping Ye
Jun Zhang
author_sort Xiaona Huo
title Perfluoroalkyl substances in early pregnancy and risk of hypertensive disorders of pregnancy: A prospective cohort study
title_short Perfluoroalkyl substances in early pregnancy and risk of hypertensive disorders of pregnancy: A prospective cohort study
title_full Perfluoroalkyl substances in early pregnancy and risk of hypertensive disorders of pregnancy: A prospective cohort study
title_fullStr Perfluoroalkyl substances in early pregnancy and risk of hypertensive disorders of pregnancy: A prospective cohort study
title_full_unstemmed Perfluoroalkyl substances in early pregnancy and risk of hypertensive disorders of pregnancy: A prospective cohort study
title_sort perfluoroalkyl substances in early pregnancy and risk of hypertensive disorders of pregnancy: a prospective cohort study
publisher Elsevier
series Environment International
issn 0160-4120
publishDate 2020-05-01
description Background: Perfluoroalkyl substances (PFASs) were reported to be associated with hypertensive disorders of pregnancy (HDP) but the results were inconsistent and prospective data are scarce. We aimed to examine these associations in a large prospective birth cohort study in Shanghai, China. Methods: A total of 10 PFASs were measured by high-performance liquid chromatography/tandem mass spectrometry (HPLC/MS-MS) in the plasma samples from 3220 women who were enrolled during early pregnancy and gave birth to a singleton live birth between 2013 and 2016. The outcomes included gestational hypertension (GH), preeclampsia (PE) and overall HDP. Associations of these outcomes with each PFASs were estimated by multivariable logistic regression and expressed as odd ratios (ORs) and 95% confidence intervals (95% CIs). Potential non-linear association between PFASs and HDP was examined with restricted cubic spline model. To handle the potential confounding by correlated PFASs, we applied elastic net regression (ENR) to identify independent PFASs components of outcomes. Results: Among all singleton live births, the incidence rates of GH and PE were 2.0% and 2.2%, respectively. Overall, PFASs did not show a significant and consistent pattern of the associations with GH, PE or overall HDP, both before and after controlling for potential confounders. ENR model confirmed the results that there was no independently predictive role of PFASs on GH, PE or overall HDP. Conclusions: In this large prospective cohort study, maternal plasma concentration of PFASs in early pregnancy were not associated with GH, PE or overall HDP in singleton livebirths. Keywords: Perfluoroalkyl substances, Gestational hypertension, Preeclampsia, Hypertensive disorders of pregnancy
url http://www.sciencedirect.com/science/article/pii/S016041201934293X
work_keys_str_mv AT xiaonahuo perfluoroalkylsubstancesinearlypregnancyandriskofhypertensivedisordersofpregnancyaprospectivecohortstudy
AT ronghuang perfluoroalkylsubstancesinearlypregnancyandriskofhypertensivedisordersofpregnancyaprospectivecohortstudy
AT yuexingan perfluoroalkylsubstancesinearlypregnancyandriskofhypertensivedisordersofpregnancyaprospectivecohortstudy
AT kailuo perfluoroalkylsubstancesinearlypregnancyandriskofhypertensivedisordersofpregnancyaprospectivecohortstudy
AT ruxianguliaimuzi perfluoroalkylsubstancesinearlypregnancyandriskofhypertensivedisordersofpregnancyaprospectivecohortstudy
AT minnian perfluoroalkylsubstancesinearlypregnancyandriskofhypertensivedisordersofpregnancyaprospectivecohortstudy
AT junjieao perfluoroalkylsubstancesinearlypregnancyandriskofhypertensivedisordersofpregnancyaprospectivecohortstudy
AT lipingfeng perfluoroalkylsubstancesinearlypregnancyandriskofhypertensivedisordersofpregnancyaprospectivecohortstudy
AT yingtian perfluoroalkylsubstancesinearlypregnancyandriskofhypertensivedisordersofpregnancyaprospectivecohortstudy
AT weiyewang perfluoroalkylsubstancesinearlypregnancyandriskofhypertensivedisordersofpregnancyaprospectivecohortstudy
AT weipingye perfluoroalkylsubstancesinearlypregnancyandriskofhypertensivedisordersofpregnancyaprospectivecohortstudy
AT junzhang perfluoroalkylsubstancesinearlypregnancyandriskofhypertensivedisordersofpregnancyaprospectivecohortstudy
_version_ 1724698766988017664
spelling doaj-b10280cfd73c4954a4473c3fd3723ce22020-11-25T03:00:20ZengElsevierEnvironment International0160-41202020-05-01138Perfluoroalkyl substances in early pregnancy and risk of hypertensive disorders of pregnancy: A prospective cohort studyXiaona Huo0Rong Huang1Yuexin Gan2Kai Luo3Ruxianguli Aimuzi4Min Nian5Junjie Ao6Liping Feng7Ying Tian8Weiye Wang9Weiping Ye10Jun Zhang11MOE-Shanghai Key Laboratory of Children’s Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine. 1665 Kong Jiang Road, Shanghai 200092, ChinaMOE-Shanghai Key Laboratory of Children’s Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine. 1665 Kong Jiang Road, Shanghai 200092, ChinaMOE-Shanghai Key Laboratory of Children’s Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine. 1665 Kong Jiang Road, Shanghai 200092, ChinaMOE-Shanghai Key Laboratory of Children’s Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine. 1665 Kong Jiang Road, Shanghai 200092, China; School of Public Health, Shanghai Jiao Tong University School of Medicine, 227 South Chongqing Road, Shanghai 200052, ChinaMOE-Shanghai Key Laboratory of Children’s Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine. 1665 Kong Jiang Road, Shanghai 200092, China; School of Public Health, Shanghai Jiao Tong University School of Medicine, 227 South Chongqing Road, Shanghai 200052, ChinaMOE-Shanghai Key Laboratory of Children’s Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine. 1665 Kong Jiang Road, Shanghai 200092, China; School of Public Health, Shanghai Jiao Tong University School of Medicine, 227 South Chongqing Road, Shanghai 200052, ChinaMOE-Shanghai Key Laboratory of Children’s Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine. 1665 Kong Jiang Road, Shanghai 200092, ChinaMOE-Shanghai Key Laboratory of Children’s Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine. 1665 Kong Jiang Road, Shanghai 200092, ChinaMOE-Shanghai Key Laboratory of Children’s Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine. 1665 Kong Jiang Road, Shanghai 200092, China; School of Public Health, Shanghai Jiao Tong University School of Medicine, 227 South Chongqing Road, Shanghai 200052, ChinaMOE-Shanghai Key Laboratory of Children’s Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine. 1665 Kong Jiang Road, Shanghai 200092, ChinaDepartment of Obstetrics and Gynecology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 1665 Kong Jiang Road, Shanghai 200092, China; Corresponding authors at: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 1665 Kong Jiang Road, Shanghai 200092, China (J. Zhang).MOE-Shanghai Key Laboratory of Children’s Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine. 1665 Kong Jiang Road, Shanghai 200092, China; School of Public Health, Shanghai Jiao Tong University School of Medicine, 227 South Chongqing Road, Shanghai 200052, China; Corresponding authors at: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 1665 Kong Jiang Road, Shanghai 200092, China (J. Zhang).Background: Perfluoroalkyl substances (PFASs) were reported to be associated with hypertensive disorders of pregnancy (HDP) but the results were inconsistent and prospective data are scarce. We aimed to examine these associations in a large prospective birth cohort study in Shanghai, China. Methods: A total of 10 PFASs were measured by high-performance liquid chromatography/tandem mass spectrometry (HPLC/MS-MS) in the plasma samples from 3220 women who were enrolled during early pregnancy and gave birth to a singleton live birth between 2013 and 2016. The outcomes included gestational hypertension (GH), preeclampsia (PE) and overall HDP. Associations of these outcomes with each PFASs were estimated by multivariable logistic regression and expressed as odd ratios (ORs) and 95% confidence intervals (95% CIs). Potential non-linear association between PFASs and HDP was examined with restricted cubic spline model. To handle the potential confounding by correlated PFASs, we applied elastic net regression (ENR) to identify independent PFASs components of outcomes. Results: Among all singleton live births, the incidence rates of GH and PE were 2.0% and 2.2%, respectively. Overall, PFASs did not show a significant and consistent pattern of the associations with GH, PE or overall HDP, both before and after controlling for potential confounders. ENR model confirmed the results that there was no independently predictive role of PFASs on GH, PE or overall HDP. Conclusions: In this large prospective cohort study, maternal plasma concentration of PFASs in early pregnancy were not associated with GH, PE or overall HDP in singleton livebirths. Keywords: Perfluoroalkyl substances, Gestational hypertension, Preeclampsia, Hypertensive disorders of pregnancyhttp://www.sciencedirect.com/science/article/pii/S016041201934293X